Ana Karla Guedes de Melo

Universidade Federal da Paraíba · PB · 24 publicações em 2022–2026

Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesVasculitis and related conditionsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Principais coautores no Nordeste tamanho = publicações em comum

Rejane Maria Rodrigues de Abreu Vieira Adah Sophia Rodrigues Vieira Cláudia Diniz Lopes Marques T. Santos Melo Alessandra de Sousa Braz Tâmara Santos Melo Danielle Christinne Soares Egypto de Brito Valéria Bezerra da Silva Adriana María Kakehasi Alessandra Sousa Braz Alexia L. H. Gama Amanda Rosa Leal de Oliveira

Publicações recentes

2026 4

Acute immune-mediated hepatocellular injury temporally associated with romosozumab: a probable autoimmune-like drug-induced liver injury
Farmacologia e toxicologia · Osteoporosis International
Brazilian Society of Rheumatology – 2025 recommendations on vaccination in immune-mediated rheumatic diseases
Medicina · Revista Brasileira de Reumatologia
Immunogenicity, Safety, and Clinical Outcomes Following Homologous and Heterologous SARS-CoV-2 Vaccination Regimens in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Prospective Observational Study from the SAFER Cohort
Medicina · Vaccines
Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease
Medicina · Pediatric Research

2025 6

Neuropathic pain and central sensitization in patients with rheumatoid arthritis attending a tertiary hospital
Medicina · Revista Brasileira de Reumatologia
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort
Medicina · Revista Brasileira de Reumatologia
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis
Medicina · Frontiers in Immunology
Reply to the letter on “Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?”
Medicina · Revista Brasileira de Reumatologia
Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study
Medicina · Vaccines
Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases
Medicina · Revista Brasileira de Reumatologia

2024 7

Fibromyalgia comorbidity in Systemic Lupus Erythematosus patients: assessing impact on quality of life
Medicina · Revista Brasileira de Reumatologia
Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer
Medicina · Revista Brasileira de Reumatologia
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort
Medicina · Vaccines
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study
Medicina · Vaccines
AB0078 PREDICTORS OF HOSPITALIZATION DUE TO BREAKTHROUGH COVID-19 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES: DATA FROM SAFER STUDY
Medicina · Annals of the Rheumatic Diseases
POS0572 FACTORS ASSOCIATED WITH VACCINE RESPONSE AFTER COVID VACCINE BOOSTER IN PATIENTS WITH AUTOIMMUNE DISEASES: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY
Medicina · Annals of the Rheumatic Diseases
AB0581 BIVALENT MRNA COVID-19 VACCINE BOOSTER DOES NOT INCREASE THE RISK OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS UNDER REAL LIFE SETTING – DATA FROM SAFER STUDY
Medicina · Annals of the Rheumatic Diseases

2023 5

Brazilian society of rheumatology methodological guide for the development of evidence-based clinical guidelines in rheumatology
Medicina · Revista Brasileira de Reumatologia
POS0271 HETEROLOGOUS COVID-19 BOOSTER VACCINATION PRODUCED GREATER ANTIBODY TITERS IN AUTOIMMUNE DISEASE PATIENTS: DATA FROM MULTICENTRIC PROSPECTIVE PHASE IV SAFER STUDY
Medicina · Annals of the Rheumatic Diseases
AB1316 SAFETY AND IMMUNOGENICITY OF TWO HETEROLOGOUS VACCINE SCHEDULES AGAINST SARS-CoV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTER STUDY
Medicina · Annals of the Rheumatic Diseases
AB1283 COVID-19 WAS NOT TRIGGER FOR RHEUMATIC DISEASE ACTIVITY AFTER 6 MONTHS FOLLOW-UP: RESULTS FROM REUMACOV BRASIL REGISTER
Medicina · Annals of the Rheumatic Diseases
Deformidade do nariz em sela em doenças reumatológicas: Uma revisão
Medicina · Research Society and Development

2022 2

Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force
Medicina · Revista Brasileira de Reumatologia
Update to “guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force”
Medicina · Revista Brasileira de Reumatologia

Contagens só com publicações em revistas com Qualis (filtro na tela inicial). Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.